Background Prior evidence suggests a link between inflammation and hypertension.
Interleukin-6 (IL-6) has been implicated in animal studies to play an important role in …

Objective: Inflammation has been proposed as a key component in the development of
hypertension and cardiac remodeling associated with different cardiovascular diseases …

Plasma levels of IL-6 correlate with high blood pressure under many circumstances, and
ANG II has been shown to stimulate IL-6 production from various cell types. This study tested …

Abstract Interleukin-6 (IL-6), the major proinflammatory cytokine, has been described to be
associated with the hypertensive and atherosclerotic states. We aimed to explore whether …

Hypertension as a multifactorial pathology is one of the most important cardiovascular risk
factors, affecting up to 30‐40% of the general population. Complex immune responses are …

Hypertension has been recognized as a multi-factorial trait resulting from the effect of a
combination of environmental and genetic factors, including excess dietary salt or alcohol …

This study tested the hypothesis that angiotensin promotes oxidative stress and
inflammation in humans via aldosterone and the mineralocorticoid receptor. We measured …

EPIDEMIOLOGICAL and experimental studies have revealed an association between
biochemical markers of systemic inflammation and cardiovascular disease such as …

Inflammation plays an important role in the development of atherosclerosis, but the specific
stimuli governing cytokine release in atherogenesis are unknown. We examined the …

Abstract Purpose of Review Mechanisms facilitating progression of hypertension via cross
stimulation of the renin-angiotensin system (RAS) and inflammation have been proposed …